GlassScriptPhysician profile
Dino Madonna
NPI 1780684399
$570.23
in general payments reported to CMS, 2019-2025
12 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.11 · 2020: $98.19 · 2021: $98.27 · 2022: $108 · 2023: $58.23 · 2024: $59.40 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $162.47 | 2020-2025 | Affinity, Puraply |
| Stryker Corporation | $85.74 | 2021-2025 | Audion Et Dilation System |
| Genzyme Corporation | $69.27 | 2020-2024 | |
| Galderma Laboratories, L.P. | $64.66 | 2019-2022 | |
| Rayner Intraocular Lenses Limited | $35.10 | 2025 | Omidria |
| Smith+Nephew, INC. | $31.51 | 2020-2022 | |
| Medtronic, INC. | $29.27 | 2024 | Propel |
| Inspire Medical Systems, INC. | $24.71 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $21.97 | 2025 | Nucala |
| Intersect Ent, INC. | $20.21 | 2022 | |
| Hikma Pharmaceuticals USA | $13.32 | 2023 | Ryaltris |
| Glenmark Therapeutics INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dino Madonna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.